SIM1: A Key Protein in The Regulation of Ion Transport and Other Physiological Processes

Target Name: SIM1

NCBI ID: G6492

SIM1

SIM1: A Key Protein in The Regulation of Ion Transport and Other Physiological Processes

SIM1 (Solute carrier system family 1 member 14) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a transmembrane protein that plays a crucial role in the transport of solutes, such as ions and nutrients, across the blood-brain barrier. SIM1 is a key component of the solute carrier system, which is a complex protein-carrier system that is responsible for the transport of solutes across the membrane of cells.

SIM1 is composed of four distinct subunits, which are encoded by the SIM1 gene. The four subunits are composed of a transmembrane region, an extracellular region, and a cytoplasmic tail. The transmembrane region of SIM1 is responsible for the formation of the protein channel, which is the channel through which solutes pass through the blood-brain barrier. The extracellular region of SIM1 is involved in the regulation of the activity of the channel, and the cytoplasmic tail is responsible for the localization of the protein within the cell.

SIM1 is a critical protein that is involved in the regulation of a wide range of physiological processes in the body. It is involved in the transport of a variety of solutes, including ions, nutrients, and medications that are essential for the maintenance of cellular homeostasis . For example, SIM1 is involved in the transport of sodium ions across the blood-brain barrier, which is necessary for the proper functioning of neurons and the regulation of brain temperature.

In addition to its role in the regulation of ion transport, SIM1 is also involved in the regulation of the delivery of other molecules across the membrane of cells. For example, SIM1 is involved in the delivery of neurotransmitters, such as dopamine and serotonin, across the blood-brain barrier, which is necessary for the proper functioning of the nervous system.

SIM1 is also involved in the regulation of the activity of other proteins that are involved in the transport of solutes across the membrane of cells. For example, SIM1 is co-expressed with the transmembrane protein TRPV4, which is involved in the regulation of pain perception . Together, SIM1 and TRPV4 are involved in the regulation of the activity of pain-related genes.

SIM1 is also involved in the regulation of the activity of the cytoplasmic enzymes that are responsible for the internalization of foreign molecules, such as toxins and foreign particles. These enzymes are important for the detoxification and elimination of harmful substances that are introduced into the body.

SIM1 is also involved in the regulation of the activity of the immune system, which is responsible for the defense against infection and inflammation. For example, SIM1 is involved in the regulation of the activity of T cells, which are responsible for the recognition and response to foreign substances in the body.

In conclusion, SIM1 is a critical protein that is involved in the regulation of a wide range of physiological processes in the body. Its role in the regulation of ion transport, neurotransmitter delivery, and cytoplasmic enzyme activity is essential for the proper functioning of cells and the maintenance of cellular homeostasis. As a drug target and biomarker, SIM1 is a promising target for the development of new treatments for a variety of neurological and cardiovascular disorders.

Protein Name: SIM BHLH Transcription Factor 1

Functions: Transcriptional factor that may have pleiotropic effects during embryogenesis and in the adult

The "SIM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SIM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets